Geoffrey Shapiro

72PUBLICATIONS

621CO-AUTHORS

Molecular targetsRadiation therapyPredictive and prognostic markersNeurology and neuromuscular diseasesCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (72)

Sort by Publication Date:

|Jul 13, 2026

Avutometinib, Abemaciclib, and Fulvestrant in Patients with HR+/HER2- Metastatic Breast Cancer Previously Treated with CDK4/6 Inhibitor: A Single-Arm Phase I Trial.

|May 26, 2026

Fibroblast growth factor receptor inhibition for succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 2 trial.

|May 07, 2026

Multicenter, Randomized, Phase II Trial of Olaparib Plus Radium-223 Versus Radium-223 in Men With Castration-Resistant Prostate Cancer With Bone Metastases (COMRADE).

|May 04, 2026

Targeting FGFR signaling overcomes therapeutic resistance and immune evasion in oncogenic PIK3CA-driven serous-like endometrial cancer.

|Mar 18, 2026

Regulation of the immune CD155-CD226-TIGIT axis by cyclin D-CDK4/6.

Anne Fassl, Miriam Palacios Espinoza, Deborah Butter

|Feb 13, 2026

A Phase II Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2.

Brandon M Huffman, Miklos Diossy, Matthew B Yurgelun

Pageof 12

Frequent Collaborators

18 joint publications

Alan D'Andrea

Bose S Kochupurakkal

Christopher A French

James M Cleary

Lynette Sholl

Brian M Wolpin

Andrew J Aguirre

Jia Luo

Sara M Tolaney

Srivatsan Raghavan

Frequent Collaborators

18 joint publications

Alan D'Andrea

8 joint publications

Bose S Kochupurakkal

8 joint publications

Christopher A French

7 joint publications

James M Cleary